Cell-based articular cartilage repair: the link between development and regeneration

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biotechnology

Background:

• Articular cartilage (AC) has limited intrinsic repair capacity, hindering clinical treatments.
• Current cell-based therapies often fail to produce hyaline cartilage, leading to degeneration and osteoarthritis (OA).
• Existing methods using bone marrow mesenchymal stem cells (MSCs) or chondrocytes result in fibrocartilage or hypertrophy.

Purpose of the Study:

• To review recent advancements in cell-based articular cartilage repair strategies.
• To highlight novel cell sources and molecular targets for improved AC regeneration.
• To discuss the potential of synovial stem cells and transcriptional regulators in AC repair.

Main Methods:

• Literature review of current research in articular cartilage repair.
• Analysis of studies on cell sources, including chondrocytes, bone marrow MSCs, pluripotent stem cells, and synovial cells.
• Examination of findings related to chondrocyte hypertrophy and metabolic balance in AC.

Main Results:

• Synovium-derived chondrocytes demonstrate stable chondrogenic activity, offering a promising alternative cell source.
• Transcription factors NFAT1 and NFAT2 are identified as key regulators inhibiting chondrocyte hypertrophy and maintaining AC homeostasis.
• The use of synovial MSCs and understanding of regulatory pathways present new avenues for AC regeneration.

Conclusions:

• Synovium represents a viable and effective cell source for articular cartilage repair.
• Targeting specific transcription factors like NFAT1/NFAT2 can prevent chondrocyte hypertrophy and promote hyaline cartilage formation.
• Advances in cell sourcing and molecular regulation offer improved therapeutic strategies for AC regeneration and OA prevention.